Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Centhaquine

Generic Name: Centhaquine

Drug Type: Small Molecule

Chemical Formula: C_₂₂H_₂₅N_₃

CAS Number: 57961-90-7

Unique Ingredient Identifier: QD4VI0J9T5

Overview

Centhaquine is under investigation in clinical trial NCT04045327 (Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock).

Background

Centhaquine is under investigation in clinical trial NCT04045327 (Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients

Phase 4

Recruiting

Posted: 2023/07/21

Sponsor:Pharmazz, Inc.

ID:NCT05956418

A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent

Phase 3

Not yet recruiting

Posted: 2022/02/22

Sponsor:Pharmazz, Inc.

ID:NCT05251181

Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in COVID-19 Patients With ARDS

Phase 2

Not yet recruiting

Posted: 2022/02/15

Sponsor:Pharmazz, Inc.

ID:NCT05241067

PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic Shock

Phase 2

Completed

Posted: 2019/08/14

Sponsor:Pharmazz, Inc.

ID:NCT04056065

Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock

Phase 3

Completed

Posted: 2019/08/05

Sponsor:Pharmazz, Inc.

ID:NCT04045327

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy